DS
CASI

David Shaw’s CASI Pharmaceuticals CASI Stock Holding History

David Shaw’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,260
Closed -$54K – 4763
2021
Q1 		$54K Buy
+2,260
New +$63.5K ﹤0.01% 3960
2020
Q4 		– Sell
-5,085
Closed -$78K – 3931
2020
Q3 		$78K Buy
+5,085
New +$95.8K ﹤0.01% 3728
2018
Q4 		– Sell
-2,198
Closed -$103K – 3767
2018
Q3 		$103K Buy
+2,198
New +$153K ﹤0.01% 3618

Other funds holding CASI

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
IACGFIA
IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

David Shaw's CASI Position: Q2 2021 in Review

David Shaw sold out of CASI Pharmaceuticals (CASI) in Q2 2021, closing a stake of 2,260 shares — an estimated $54K sold.

David Shaw first reported a position in CASI in Q3 2018 and held it in 3 quarters. The position peaked at $103K in Q3 2018. 68 funds tracked by Wall St. Rank hold CASI as of Q2 2021.

  • David Shaw reported no remaining CASI Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • David Shaw sold 2,260 CASI Pharmaceuticals shares in Q2 2021, an estimated $54K.
  • David Shaw first reported a position in CASI Pharmaceuticals in Q3 2018 and held it in 3 quarters.
  • David Shaw's CASI Pharmaceuticals position peaked at $103K in Q3 2018.
  • 68 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2021.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.